Spine company sees strong 24-month patient outcomes for spinal cord stimulation

Two-year data of Saluda Medical’s Evoke spinal cord stimulation system showed strong clinical results.

Advertisement

Long-term evidence found all patients treated with Evoke were “clinically significant responders in at least one outcome measure of pain relief, function, sleep, quality of life, or mood,” according to a July 19 news release. One in two Evoke patients also saw a holistic outcome response.

The Evoke system is the only smart spinal cord stimulator that senses and measures responses to stimulation, according to Saluda Medical. It can adjust therapy more than 4 million times daily for chronic pain patients.

The study, published in Pain, can be read here.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.